Search
-
Leading pharmaceutical brands demonstrating leadership
As Covid-19 continues to disrupt traditional care norms, major pharma products have an unprecedented opportunity to define new market dynamics and demonstrate population health leadership.
-
Assessing the risk profile of recently launched drugs
Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.
-
People are divided over whether the economy should open if COVID-19 is not fully contained
Hard hit Italy and China support reopening.
-
Signals #4: Understanding the coronavirus crisis
This fourth edition sees us bring together our latest research on coronavirus and draws on our surveys, social media monitoring and the analysis of our teams around the world.
-
Future uncertainty: Why people don’t see a quick economic recovery from coronavirus
Consumer confidence and poll on economic outlook show doubts about recovery ahead.
-
Ipsos joins an international partnership to implement non-pharmaceutical interventions against Covid-19 in Africa
Ipsos will provide the collection and analysis of data on the impact of COVID-19, behaviours surrounding it, and control measures put in place in African countries.
-
Many think it’s unlikely the economy will recover quickly once COVID-19 lockdown is over
Most negative about an economic recovery in hard-hit countries except China.
-
Multi-source healthcare data
The world of pharma business insight is likely to change as it embraces a multi-data source reality.
-
More people say they’re wearing masks to protect themselves from COVID-19 since March
There’s been an increase in the number of people wearing masks in many countries.
-
Live occupancy tracker for essential retailers
Covid-19 has had a dramatic impact on where, when and how we are able to interact with our world. For hospitals, pharmacies and ‘essential’ retailers in particular, the new social distancing guidelines have made store traffic an even more crucial data metric.